Permapen

NDA 60014, held by Casper Pharma LLC. Penicillin G Benzathine.

As of Nov 13, 2026, NDA 60014 (Permapen), held by Casper Pharma LLC, was first approved by FDA on Dec 16, 1952, with 2 approved supplements and 0 published complete response letters.

First approved: Dec 16, 1952
Supplements approved: 2
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 3 submissions below

Date	Submission	Status	Documents
Dec 16, 1952	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Permapen600,000 UNITS/ML · injectable;injection	Penicillin G Benzathine	Discontinued

All 3 submissions, including labeling and manufacturing supplements


Feb 18, 2000	Supplement 2Labeling	Approved	None posted
Aug 8, 1989	Supplement 1Manufacturing	Approved	None posted
Dec 16, 1952	Original application	Approved	None posted

Identifiers

Application: NDA 60014
Drugs@FDA: Overview at FDA
Company: Casper Pharma

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters